Cargando…
Circulating tumor cells detection in neuroblastoma patients by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization
Detecting circulating tumor cells (CTCs) has proven valuable for evaluating the prognosis of cancer patients and for studying the mechanisms of treatment resistance. Owing to the lack of universal and specific tumor markers for neuroblastoma (NB), in this prospective study, we adopted an EpCAM-indep...
Autores principales: | Liu, Xiangqi, Zhang, Zhenzhen, Zhang, Binbin, Zheng, Yijie, Zheng, Chao, Liu, Baihui, Zheng, Shan, Dong, Kuiran, Dong, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154868/ https://www.ncbi.nlm.nih.gov/pubmed/30104180 http://dx.doi.org/10.1016/j.ebiom.2018.08.005 |
Ejemplares similares
-
Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization
por: Zhang, Yaowen, et al.
Publicado: (2019) -
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014) -
Leukocyte-Derived Extracellular Vesicles in Blood with and without EpCAM Enrichment
por: Nanou, Afroditi, et al.
Publicado: (2019) -
Expression of EpCAM in uveal melanoma
por: Odashiro, Danilo N, et al.
Publicado: (2006)